Abstract: A method for checking the quality of a workpiece, a surface section of the workpiece is finished with a manufacturing device. A reference signal representing a time dependent difference between an ideal tool position and a real tool position of a tool of the manufacturing device in a reference phase is determined when finishing the workpiece. A test signal representing a time dependent difference between an ideal tool position and a real tool position of a tool of the manufacturing device in an operation phase is determined when finishing the workpiece. A mean value and a standard deviation value from the reference signal is determined. Data points of the test signal are determined, where the test signal deviates from the mean value more than a defined multiple of the standard deviation value. The surface quality of the workpiece is estimated by using the determined data points.

Abstract: A method for checking the quality of a workpiece, a surface section of the workpiece is finished with a manufacturing device. A reference signal representing a time dependent difference between an ideal tool position and a real tool position of a tool of the manufacturing device in a reference phase is determined when finishing the workpiece. A test signal representing a time dependent difference between an ideal tool position and a real tool position of a tool of the manufacturing device in an operation phase is determined when finishing the workpiece. A mean value and a standard deviation value from the reference signal is determined. Data points of the test signal are determined, where the test signal deviates from the mean value more than a defined multiple of the standard deviation value. The surface quality of the workpiece is estimated by using the determined data points.

Abstract: The present invention discloses 3,4-dihydroquinoxalin-2(1H)-ones for use as inhibitors of stearoyl-CoA desaturase. The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, oily skin conditions, metabolic syndrome, and the like.

Abstract: The present invention discloses bicyclic nitrogen-containing heterocyclic compounds for use as inhibitors of stearoyl-CoA desaturase. The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, oily skin conditions, metabolic syndrome, and the like.

Abstract: The present invention discloses pyrido[2,3-B]pyrazin-3(4h)-ones for use as inhibitors of stearoyl-CoA desaturase. The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, oily skin conditions, metabolic syndrome, and the like.

Abstract: The present invention discloses pteridinone derivatives for use as inhibitors of stearoyl-CoA desaturase having the structure of Formula I: The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome and the like.

Abstract: The present invention discloses pteridinone derivatives for use as inhibitors of stearoyl-CoA desaturase having the structure of Formula I: The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome and the like.

Abstract: The present invention discloses pteridinone derivatives for use as inhibitors of stearoyl-CoA desaturase having the structure of Formula I: The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome and the like.

Abstract: The present invention discloses bicyclic nitrogen-containing heterocyclic compounds for use as inhibitors of stearoyl-CoA desaturase. The compounds are useful in treating and/or preventing various human diseases, mediated by stearoyl-CoA desaturase (SCD) enzymes, especially diseases related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, oily skin conditions, metabolic syndrome, and the like.